{"entity":{"id":"inca-brazil","kind":"institution","name":"Instituto Nacional de Câncer (INCA)","aka":["INCA","Instituto Nacional de Câncer José Alencar Gomes da Silva"],"tldr":"Brazil's national cancer institute, the Ministry of Health body that runs cancer control, registries and screening for the country and treats patients in its Rio hospitals.","summary":"INCA was created in 1937 and is the Brazilian Ministry of Health's agency for national cancer policy, running the population and hospital cancer registries, cancer incidence estimates, the national tobacco control programme (a global model recognised by WHO), and cervical and breast screening guidelines for the public health system (SUS). It operates several hospital units in Rio de Janeiro providing surgical, medical, radiation and paediatric oncology and bone marrow transplant, hosts a research centre in cancer biology, epidemiology and clinical trials, and coordinates Brazil's national bone marrow donor registry (REDOME), one of the largest in the world. INCA trains oncology specialists nationally and publishes the reference Estimativa reports on Brazil's cancer burden.","asOf":"2026-09-09","links":[{"label":"INCA","url":"https://www.gov.br/inca"}],"tags":[],"related":["global-oncology-access","cancer-registries-surveillance"],"cancers":["cervical","breast-hr-positive","prostate","nsclc","all-leukemia"],"sections":["prevention","early-detection"],"technologies":["allogeneic-cell-therapy","hpv-vaccine"],"targets":[],"drugs":[],"companies":[],"institutions":["iarc"],"pathways":[],"terms":[],"trials":[],"people":["roberto-de-almeida-gil"],"bottlenecks":[],"keyPapers":[],"journals":[],"dependsOn":[],"notes":[],"city":"Rio de Janeiro","country":"BR","lat":-22.911,"lng":-43.185,"institutionType":"government","website":"https://www.gov.br/inca","programs":["National cancer control and registries","Tobacco control","REDOME bone marrow registry","Hospital units and research centre"]},"route":"/institutions/inca-brazil/","neighbours":{"technology":[{"id":"allogeneic-cell-therapy","kind":"technology","name":"Allogeneic (off-the-shelf) cell therapy","route":"/technologies/allogeneic-cell-therapy/"},{"id":"cancer-registries-surveillance","kind":"technology","name":"Cancer registries and population surveillance","route":"/technologies/cancer-registries-surveillance/"},{"id":"global-oncology-access","kind":"technology","name":"Global oncology and access in low- and middle-income countries","route":"/technologies/global-oncology-access/"},{"id":"hpv-vaccine","kind":"technology","name":"HPV & HBV vaccination","route":"/technologies/hpv-vaccine/"}],"cancer":[{"id":"all-leukemia","kind":"cancer","name":"Acute lymphoblastic leukaemia","route":"/cancers/all-leukemia/"},{"id":"cervical","kind":"cancer","name":"Cervical cancer","route":"/cancers/cervical/"},{"id":"breast-hr-positive","kind":"cancer","name":"HR-positive / HER2-negative breast cancer","route":"/cancers/breast-hr-positive/"},{"id":"nsclc","kind":"cancer","name":"Non-small-cell lung cancer","route":"/cancers/nsclc/"},{"id":"prostate","kind":"cancer","name":"Prostate cancer","route":"/cancers/prostate/"}],"section":[{"id":"early-detection","kind":"section","name":"Early Detection & Screening","route":"/fronts/early-detection/"},{"id":"prevention","kind":"section","name":"Prevention & Risk","route":"/fronts/prevention/"}],"institution":[{"id":"erasto-gaertner","kind":"institution","name":"Hospital Erasto Gaertner","route":"/institutions/erasto-gaertner/"},{"id":"icesp","kind":"institution","name":"Instituto do Câncer do Estado de São Paulo (ICESP)","route":"/institutions/icesp/"},{"id":"iarc","kind":"institution","name":"International Agency for Research on Cancer (IARC / WHO)","route":"/institutions/iarc/"}],"person":[{"id":"roberto-de-almeida-gil","kind":"person","name":"Roberto de Almeida Gil","route":"/people/roberto-de-almeida-gil/"}]}}